China Finalizes IPO Listing Rules for Shanghai High-Tech Board

Life Science

SOL Global Announces Formation of International Hemp Company Heavenly Rx

Cannabis, Life Science

ATLATL Innovation Cluster: An Evolved Kendall Square Miniature in China

Life Science

Aurora Completes Whistler Medical Acquisition

Cannabis, Life Science

Lilly to launch a half-price version of insulin

Life Science

3SBio Will Pay $50 Million Upfront for China Rights to Two TLC Products

Life Science

WuXi Biologics Signs $220 Million Bi-Specific Deal with ABL Bio of South Korea

Life Science

Our Newest Client Increased 229% in One Month! – This and Other Featured Opportunities on NAI500

Cannabis, Life Science

Kemin Invests in China to Become Basic in Enzyme Ingredients

Life Science

Aslan Out-Licenses Korean Rights for Oncology Drug in $13 Million Deal

Life Science

China Strengthens Clinical Trial Approval Rules for Cell and Gene Therapies

Life Science

Cutting in on an Entegris Deal, Merck KGaA Makes $5.9 Billion Bid for Versum

Life Science

Nanjing’s NJCTTQ Signs $4 Billion In-Licensing Deal for Bi-Specific Immunotherapies from Abpro

Life Science

Titan Medical Expands Global Intellectual Property Portfolio to 30 Patents Issued and 75 Pending with Receipt of First Patent in China

Life Science

Choom Signs Definitive Agreement to Acquire Clarity Cannabis Retail Stores in Alberta

Life Science